NeurologyLive Friday 5 — September 17, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 17, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: The Nature of MS and the Role of the MS Team

In the first session of the "Managing Multiple Sclerosis: A Team Approach" broadcast series, Patty Bobryk, PT, and Colleen Harris, MN, NP, MCSN, MSCS, discuss the nature of multiple sclerosis and the role of the MS team. This CME/CE broadcast series provides expert insight on and review of clinical issues faced by patients with MS, with experts in these fields discussing how to address barriers, apply expert recommendations, and more.

2: Trends in Migraine: COVID’s Impact and Barriers to Treatment

Deena Kuruvilla, MD, director, Westport Headache Institute, offered her insight into the trends in the clinical care of migraine and the effect that the pandemic has had on patients. Particularly, with this year’s annual American Headache Society meeting having taken place in June, she spoke to the larger topics of conversation that headache clinicians were focused on while gathered for the meeting.

3: NeuroVoices: Michael Dwyer, PhD, on Clinical Impact of AI in Neuroimaging

The director of IT and Neuroinformatics Development at the Buffalo Neuroimaging provided thoughts on artificial intelligence’s role in neuroimaging and treating multiple sclerosis. He also provided context on the work being done at the center, the potential of these AI-based modalities, and ways clinicians can benefit the most from them.

4: The Shortage of Neurologists’ Effect on Patient Care: Jennifer Majersik, MD, MS

The division chief of vascular neurology at the University of Utah discussed the driving force behind the national shortage of neurologists and its effect on patient care, positing that neurologists are somewhat “victims of our own success,” due to efforts in identifying effective treatments and the resultant increase in care demands with limited providers to meet them.

5: Takeaways From the Second Annual Student Sleep Health Week

Raman Malhotra, MD, president of the American Academy of Sleep Medicine, discussed the initiative, which emphasizes the importance of healthy sleep for students, calling for specific attention to the negative implications associated with lack of sleep, which can affect overall health, as well as performance in school and extracurricular activities.

——————————————————

The 3rd Annual International Congress on the Future of Neurology® started TODAY! The virtual meeting, which will showcase the most recent advancements in neurologic disorders, will be held September 17 and 18, 2021. The target audience for this activity is physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.

The learning objectives of the program are:

  • Outline current and emerging diagnostic concepts for neurologic disorders
  • Explain clinical evidence for the management of neurologic disorders across multiple lines of care
  • Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
  • Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies
  • Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
  • Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology